SCHEMBL14879729

SCHEMBL14879729

CS(=O)(=O)c1cc(C(=O)O)cc(N2CCCCC2)c1Oc1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.77
HSD17B10 Q99714 3/20 0.77
USP2 O75604 2/20 0.77
ALDH1A1 P00352 2/20 0.77
LMNA P02545 2/20 0.77
HPGD P15428 2/20 0.77
HIF1A Q16665 2/20 0.77
SLC6A4 P31645 1/20 0.77
ERAP1 Q9NZ08 6/20 0.47
ERAP2 Q6P179 2/20 0.47
SLC9A1 P19634 1/20 0.46
TSHR P16473 2/20 0.43
POLB P06746 2/20 0.43
CA2 P00918 1/20 0.41
BLM P54132 1/20 0.41
SLC12A2 P55011 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14881297 0.90 ALDH1A1 (0.63) KDM4EHSD17B10USP2ALDH1A1LMNA
SCHEMBL2741891 0.88 KDM4E (0.98) KDM4EHSD17B10USP2ALDH1A1LMNA
SCHEMBL11544834 0.87 KDM4E (0.79) KDM4EHSD17B10USP2ALDH1A1LMNA
Piretanide SCHEMBL1741994 0.87 KDM4E (1.00) KDM4EHSD17B10USP2ALDH1A1LMNA
Piretanide SCHEMBL30230376 0.87 KDM4E (1.00) KDM4EHSD17B10USP2ALDH1A1LMNA
Piretanide SCHEMBL49473 0.87 KDM4E (1.00) KDM4EHSD17B10USP2ALDH1A1LMNA
SCHEMBL11544970 0.86 ALDH1A1 (0.74) KDM4EHSD17B10USP2ALDH1A1LMNA
SCHEMBL11541860 0.86 LMNA (0.74) KDM4EHSD17B10USP2ALDH1A1LMNA
Piretanide SCHEMBL9837127 0.86 KDM4E (0.98) KDM4EHSD17B10USP2ALDH1A1LMNA
Piretanide SCHEMBL7895002 0.85 KDM4E (0.95) KDM4EHSD17B10USP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013059648-A1 2,3,5 TRISUBSTITUTED ARYL AND HETEROARYL AMINO DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2013-04-25 WO disclosed
WO-2013059648-A1 2,3,5 TRISUBSTITUTED ARYL AND HETEROARYL AMINO DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2013-04-25 WO disclosed